During CKD progression, diminished expression of FAO enzymes, together with perturbations in key nuclear receptors (PPAR-α, PPAR-γ, and FXR), alters FA uptake machinery and downstream lipid–metabolic pathways, thereby accelerating tubulointerstitial fibrosis [41]. Here, PPARG is linked to chronic kidney disease.